AR Training in Adults With Unilateral Amblyopia
Condition(s) studied
Investigational drug(s) / intervention(s)
AR training: Dichoptic augmented reality training with dual-pathway (parvocellular pathway and magnocellular pathway) and interocular push-pull paradigms developed based on neural deficits in adults with unilateral amblyopia
Patching: Conventional patching therapy.
Study summary
This is a single-center, non-randomized controlled trial to compare the effectiveness of binocular AR training with patching for the treatment of adults with unilateral amblyopia.
Specific Aim 1 (Primary): To compare the improvement of visual acuity in the amblyopic eye between AR training and patching for the treatment of adults with unilateral amblyopia.
Specific Aim 2 (Secondary): To compare the changes of visual functions and pathway selective neural activity in the early visual and cortex subcortical nuclei including the lateral geniculate nucleus between AR training and patching for the treatment of adults with unilateral amblyopia.
Eligibility
Primary outcome measure(s)
- Change in visual acuity at far — 1 week, 1month, 3month, 6month
Best-corrected visual acuity in the amblyopic eye measured at the distance of 2.5 meters using standardized logMAR visual charts.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Eye & ENT Hospital of Fudan University | Shanghai | China |
More Eye & ENT Hospital of Fudan University trials in China
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06704737 on ClinicalTrials.gov ↗ ← All trials in China